Patients with infective endocarditis undergoing cardiac surgery have distinct ROTEM profiles and more bleeding complications compared to patients without infective endocarditis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
01
2023
accepted:
28
03
2023
medline:
17
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
The coagulation system is crucial in the pathogenesis of infective endocarditis and undergoes significant changes during course of the disease. However, little is known about the implications of those changes in the perioperative period. Aim of the present study was to delineate the specific coagulation patterns and their clinical consequence in patients undergoing cardiac surgery due to infective endocarditis. In this single-centre, exploratory, prospective observational study, we investigated the incidence and degree of coagulopathy in patients with (n = 31) and without infective endocarditis (n = 39) undergoing cardiac valve surgery. The primary outcome was the differences between these two groups in rotational thromboelastometry (ROTEM) results before, during and after surgery. The secondary outcomes were the differences between the groups in heparin sensitivity, bleeding complications, and transfusion requirements. Most ROTEM parameters in EXTEM, INTEM and FIBTEM assays were significantly altered in patients with infective endocarditis. Clotting time in the EXTEM assay was significantly prolonged in the endocarditis group at all time-points, while all clot firmness parameters (A5, A10 and MCF) were significantly increased. The heparin sensitivity index was significantly lower in the endocarditis group (median index 0.99 vs 1.17s. IU-1.kg-1, p = .008), indicating increased heparin resistance. Patients with infective endocarditis had more bleeding complications as assessed by the universal definition of perioperative bleeding score (OR 3.0, p = .018), and more patients with endocarditis underwent early re-exploration (p = .018). The findings of this exploratory investigation show significantly altered coagulation profiles in patients with infective endocarditis, with concomitant hyper- and hypocoagulability. Furthermore, the incidence of bleeding complications and transfusion requirements were increased in patients with endocarditis. These results show the potential of ROTEM to detect coagulation abnormalities in patients with infective endocarditis. Existing point-of-care coagulation testing guided algorithms for optimizing perioperative coagulation management possibly need to be adjusted for these high-risk patients undergoing cardiac surgery.
Sections du résumé
BACKGROUND
The coagulation system is crucial in the pathogenesis of infective endocarditis and undergoes significant changes during course of the disease. However, little is known about the implications of those changes in the perioperative period. Aim of the present study was to delineate the specific coagulation patterns and their clinical consequence in patients undergoing cardiac surgery due to infective endocarditis.
METHODS
In this single-centre, exploratory, prospective observational study, we investigated the incidence and degree of coagulopathy in patients with (n = 31) and without infective endocarditis (n = 39) undergoing cardiac valve surgery. The primary outcome was the differences between these two groups in rotational thromboelastometry (ROTEM) results before, during and after surgery. The secondary outcomes were the differences between the groups in heparin sensitivity, bleeding complications, and transfusion requirements.
RESULTS
Most ROTEM parameters in EXTEM, INTEM and FIBTEM assays were significantly altered in patients with infective endocarditis. Clotting time in the EXTEM assay was significantly prolonged in the endocarditis group at all time-points, while all clot firmness parameters (A5, A10 and MCF) were significantly increased. The heparin sensitivity index was significantly lower in the endocarditis group (median index 0.99 vs 1.17s. IU-1.kg-1, p = .008), indicating increased heparin resistance. Patients with infective endocarditis had more bleeding complications as assessed by the universal definition of perioperative bleeding score (OR 3.0, p = .018), and more patients with endocarditis underwent early re-exploration (p = .018).
CONCLUSIONS
The findings of this exploratory investigation show significantly altered coagulation profiles in patients with infective endocarditis, with concomitant hyper- and hypocoagulability. Furthermore, the incidence of bleeding complications and transfusion requirements were increased in patients with endocarditis. These results show the potential of ROTEM to detect coagulation abnormalities in patients with infective endocarditis. Existing point-of-care coagulation testing guided algorithms for optimizing perioperative coagulation management possibly need to be adjusted for these high-risk patients undergoing cardiac surgery.
Identifiants
pubmed: 37053130
doi: 10.1371/journal.pone.0284329
pii: PONE-D-23-00762
pmc: PMC10101476
doi:
Substances chimiques
Heparin
9005-49-6
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0284329Informations de copyright
Copyright: © 2023 Breel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Medicine (Baltimore). 2019 Feb;98(5):e14219
pubmed: 30702577
Anesthesiology. 2021 Mar 1;134(3):366-369
pubmed: 33417671
Ann Thorac Surg. 2021 Feb;111(2):607-614
pubmed: 32585201
Clin Cardiol. 2021 Mar;44(3):307-315
pubmed: 33527443
Interact Cardiovasc Thorac Surg. 2018 Sep 1;27(3):328-335
pubmed: 29579243
Crit Care. 2014 Oct 08;18(5):549
pubmed: 25292221
Open Heart. 2021 Oct;8(2):
pubmed: 34670832
World J Surg. 2009 Sep;33(9):1862-7
pubmed: 19597879
Clin Cardiol. 2004 Mar;27(3):154-8
pubmed: 15049384
J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3568-3573
pubmed: 34144872
Heart Lung Circ. 2020 Jun;29(6):840-850
pubmed: 31402124
Intern Emerg Med. 2015 Aug;10(5):539-41
pubmed: 26033535
Can J Anaesth. 2006 Aug;53(8):781-94
pubmed: 16873345
Blood Coagul Fibrinolysis. 2009 Sep;20(6):419-26
pubmed: 19581801
N Engl J Med. 2021 Aug 26;385(9):826-832
pubmed: 34437785
Korean J Anesthesiol. 2019 Aug;72(4):297-322
pubmed: 31096732
J Thromb Thrombolysis. 2012 Jul;34(1):132-4
pubmed: 22302637
Korean J Anesthesiol. 2021 Apr;74(2):91-102
pubmed: 33440114
J Cardiothorac Vasc Anesth. 2011 Feb;25(1):36-41
pubmed: 20674394
Anesthesiology. 2022 Apr 1;136(4):633-656
pubmed: 35120196
Nat Rev Dis Primers. 2016 Sep 01;2:16059
pubmed: 27582414
Am J Cardiol. 2003 Mar 15;91(6):689-92
pubmed: 12633799
J Crit Care. 2018 Apr;44:7-11
pubmed: 28988002
Anesth Analg. 2013 Jun;116(6):1210-22
pubmed: 23408671
Semin Thromb Hemost. 2017 Jun;43(4):386-396
pubmed: 28359133
J Thorac Cardiovasc Surg. 2014 May;147(5):1458-1463.e1
pubmed: 24332097
Blood Coagul Fibrinolysis. 2015 Oct;26(7):778-83
pubmed: 26196197
J Cardiothorac Vasc Anesth. 2016 Jun;30(3):687-91
pubmed: 26750645
Transfusion. 2018 May;58(5):1218-1227
pubmed: 29516497
Crit Care. 2014 Feb 10;18(1):R30
pubmed: 24512650
Clin Orthop Relat Res. 2021 Nov 1;479(11):2457-2467
pubmed: 34076610
Medicine (Baltimore). 2018 Jun;97(22):e10929
pubmed: 29851830
Blood Coagul Fibrinolysis. 2019 Jul;30(5):181-187
pubmed: 31157682
PLoS One. 2021 Dec 15;16(12):e0261429
pubmed: 34910783
Lancet. 2016 Feb 27;387(10021):882-93
pubmed: 26341945
Eur J Cardiothorac Surg. 2019 Oct 01;56(4):785-792
pubmed: 30932157
J Thromb Haemost. 2020 May;18(5):995-1008
pubmed: 31925863